K
Kezar Life Sciences D
D
KZR
4.35000
USD
-0.16
(-3.55%)
مغلق
حجم التداول
2,760
الربح لكل سهم
-10
العائد الربحي
-
P/E
-0
حجم السوق
31,780,230
الأخبار المقالات
العنوان: Kezar Life Sciences Inc
القطاع: Healthcare
الصناعة: Biotechnology
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.